Cryo-cell International Inc (CCEL)

$7.45

-0.27

(-3.5%)▲

Market is closed - opens 7 PM, 29 Jul 2024

Performance

  • $7.45
    $7.64
    $7.45
    downward going graph

    0.0%

    Downside

    Day's Volatility :2.49%

    Upside

    2.49%

    downward going graph
  • $3.67
    $9.50
    $7.45
    downward going graph

    50.74%

    Downside

    52 Weeks Volatility :61.37%

    Upside

    21.58%

    downward going graph

Returns

PeriodCryo-cell International IncIndex (Russel 2000)
3 Months
-8.64%
0.0%
6 Months
39.6%
0.0%
1 Year
28.67%
0.0%
3 Years
-33.45%
-20.2%

Highlights

Market Capitalization
62.2M
Book Value
- $1.33
Earnings Per Share (EPS)
-1.12
PEG Ratio
0.0
Wall Street Target Price
11.0
Profit Margin
-29.38%
Operating Margin TTM
21.08%
Return On Assets TTM
-0.25%
Return On Equity TTM
129.2%
Revenue TTM
31.6M
Revenue Per Share TTM
3.84
Quarterly Revenue Growth YOY
3.5000000000000004%
Gross Profit TTM
21.5M
EBITDA
614.7K
Diluted Eps TTM
-1.12
Quarterly Earnings Growth YOY
2.01
EPS Estimate Current Year
0.16
EPS Estimate Next Year
0.13
EPS Estimate Current Quarter
0.04
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Buy
    85%Buy
    14%Hold
    0
    0%Sell
Based on 7 Wall street analysts offering stock ratings for Cryo-cell International Inc(by analysts ranked 0 to 5 stars)
Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
1
1
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 47.65%

Current $7.45
Target $11.00

Company Financials

FY18Y/Y Change
Revenue
29.2M
↑ 15.1%
Net Income
-854.8K
↓ 136.92%
Net Profit Margin
-2.93%
↓ 12.05%
FY19Y/Y Change
Revenue
31.8M
↑ 8.89%
Net Income
2.3M
↓ 367.98%
Net Profit Margin
7.2%
↑ 10.13%
FY20Y/Y Change
Revenue
31.1M
↓ 2.1%
Net Income
3.6M
↑ 58.23%
Net Profit Margin
11.64%
↑ 4.44%
FY21Y/Y Change
Revenue
28.9M
↓ 7.26%
Net Income
2.1M
↓ 42.52%
Net Profit Margin
7.21%
↓ 4.43%
FY22Y/Y Change
Revenue
30.3M
↑ 5.03%
Net Income
2.8M
↑ 33.02%
Net Profit Margin
9.14%
↑ 1.93%
FY23Y/Y Change
Revenue
31.3M
↑ 3.32%
Net Income
-9.5M
↓ 443.57%
Net Profit Margin
-30.38%
↓ 39.52%
Q1 FY23Q/Q Change
Revenue
7.8M
↑ 0.78%
Net Income
766.8K
↓ 8.48%
Net Profit Margin
9.8%
↓ 0.99%
Q2 FY23Q/Q Change
Revenue
7.8M
↓ 0.66%
Net Income
221.0K
↓ 71.18%
Net Profit Margin
2.84%
↓ 6.96%
Q3 FY23Q/Q Change
Revenue
7.9M
↑ 1.25%
Net Income
680.6K
↑ 207.98%
Net Profit Margin
8.65%
↑ 5.81%
Q4 FY23Q/Q Change
Revenue
7.9M
↑ 0.09%
Net Income
-11.2M
↓ 1744.23%
Net Profit Margin
-142.06%
↓ 150.71%
Q1 FY24Q/Q Change
Revenue
7.9M
↓ 0.31%
Net Income
556.2K
↓ 104.97%
Net Profit Margin
7.08%
↑ 149.14%
Q2 FY24Q/Q Change
Revenue
8.0M
↑ 2.43%
Net Income
655.8K
↑ 17.9%
Net Profit Margin
8.15%
↑ 1.07%
FY18Y/Y Change
Total Assets
42.4M
↑ 77.29%
Total Liabilities
51.3M
↑ 40.88%
FY19Y/Y Change
Total Assets
42.9M
↑ 1.17%
Total Liabilities
49.8M
↓ 2.84%
FY20Y/Y Change
Total Assets
46.2M
↑ 7.73%
Total Liabilities
48.9M
↓ 1.95%
FY21Y/Y Change
Total Assets
60.7M
↑ 31.3%
Total Liabilities
56.5M
↑ 15.58%
FY22Y/Y Change
Total Assets
64.9M
↑ 6.97%
Total Liabilities
66.4M
↑ 17.59%
FY23Y/Y Change
Total Assets
61.2M
↓ 5.65%
Total Liabilities
72.3M
↑ 8.79%
Q1 FY23Q/Q Change
Total Assets
66.1M
↑ 1.92%
Total Liabilities
66.8M
↑ 0.62%
Q2 FY23Q/Q Change
Total Assets
68.8M
↑ 3.97%
Total Liabilities
69.6M
↑ 4.18%
Q3 FY23Q/Q Change
Total Assets
69.8M
↑ 1.51%
Total Liabilities
69.8M
↑ 0.28%
Q4 FY23Q/Q Change
Total Assets
61.2M
↓ 12.29%
Total Liabilities
72.3M
↑ 3.49%
Q1 FY24Q/Q Change
Total Assets
61.7M
↑ 0.8%
Total Liabilities
72.0M
↓ 0.28%
Q2 FY24Q/Q Change
Total Assets
62.6M
↑ 1.39%
Total Liabilities
73.3M
↑ 1.75%
FY18Y/Y Change
Operating Cash Flow
5.3M
↓ 6.73%
Investing Cash Flow
-11.3M
↓ 12228.36%
Financing Cash Flow
5.7M
↓ 288.33%
FY19Y/Y Change
Operating Cash Flow
6.3M
↑ 18.56%
Investing Cash Flow
-690.7K
↓ 93.88%
Financing Cash Flow
-5.1M
↓ 189.87%
FY20Y/Y Change
Operating Cash Flow
8.5M
↑ 33.9%
Investing Cash Flow
357.5K
↓ 151.76%
Financing Cash Flow
-5.0M
↓ 2.49%
FY21Y/Y Change
Operating Cash Flow
7.9M
↓ 6.38%
Investing Cash Flow
-7.0M
↓ 2044.47%
Financing Cash Flow
-3.1M
↓ 38.59%
FY22Y/Y Change
Operating Cash Flow
8.6M
↑ 8.16%
Investing Cash Flow
-15.3M
↑ 119.81%
Financing Cash Flow
147.9K
↓ 104.81%
Q1 FY23Q/Q Change
Operating Cash Flow
1.6M
↓ 32.34%
Investing Cash Flow
-1.2M
↓ 162.75%
Financing Cash Flow
-772.8K
↓ 86.11%
Q2 FY23Q/Q Change
Operating Cash Flow
2.0M
↑ 21.0%
Investing Cash Flow
-1.6M
↑ 31.04%
Financing Cash Flow
-663.2K
↓ 14.18%
Q3 FY23Q/Q Change
Operating Cash Flow
1.9M
↓ 2.35%
Investing Cash Flow
-3.4M
↑ 115.01%
Financing Cash Flow
903.9K
↓ 236.28%

Technicals Summary

Sell

Neutral

Buy

Cryo-cell International Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Cryo-cell International Inc
Cryo-cell International Inc
-7.27%
39.6%
28.67%
-33.45%
-33.45%
Fresenius Medical Care Ag
Fresenius Medical Care Ag
6.75%
1.59%
-22.77%
-49.63%
-45.76%
Hca Holdings, Inc.
Hca Holdings, Inc.
3.62%
24.47%
25.02%
43.55%
143.2%
Tenet Healthcare Corp. 
Tenet Healthcare Corp. 
10.35%
80.65%
95.1%
108.93%
580.33%
Universal Health Services Inc.
Universal Health Services Inc.
8.08%
30.09%
44.94%
32.59%
34.96%
Davita Healthcare Partners Inc.
Davita Healthcare Partners Inc.
0.24%
32.97%
40.81%
19.01%
139.9%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Cryo-cell International Inc
Cryo-cell International Inc
17.12
NA
0.0
0.16
1.29
0.0
NA
-1.33
Fresenius Medical Care Ag
Fresenius Medical Care Ag
22.58
22.58
0.39
1.5
0.05
0.03
0.03
47.4
Hca Holdings, Inc.
Hca Holdings, Inc.
16.16
16.16
1.44
21.86
0.74
0.11
0.01
-6.06
Tenet Healthcare Corp. 
Tenet Healthcare Corp. 
5.46
5.46
1.74
8.98
0.54
0.07
NA
16.09
Universal Health Services Inc.
Universal Health Services Inc.
15.8
15.8
1.87
13.79
0.13
0.06
0.0
93.48
Davita Healthcare Partners Inc.
Davita Healthcare Partners Inc.
16.31
16.31
1.16
9.32
0.43
0.06
NA
10.56
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Cryo-cell International Inc
Cryo-cell International Inc
Buy
$62.2M
-33.45%
17.12
-29.38%
Fresenius Medical Care Ag
Fresenius Medical Care Ag
Hold
$11.9B
-45.76%
22.58
2.48%
Hca Holdings, Inc.
Hca Holdings, Inc.
Buy
$90.1B
143.2%
16.16
8.4%
Tenet Healthcare Corp. 
Tenet Healthcare Corp. 
Buy
$14.6B
580.33%
5.46
12.54%
Universal Health Services Inc.
Universal Health Services Inc.
Hold
$12.4B
34.96%
15.8
5.57%
Davita Healthcare Partners Inc.
Davita Healthcare Partners Inc.
Hold
$12.6B
139.9%
16.31
6.61%

Insights on Cryo-cell International Inc

  • Increasing Revenue

    Revenue is up for the last 2 quarters, 7.85M → 8.04M (in $), with an average increase of 2.4% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, -11.19M → 655.79K (in $), with an average increase of 1063.5% per quarter

  • Vs THC

    In the last 1 year, Tenet Healthcare Corp.  has given 95.1% return, outperforming this stock by 66.4%

Institutional Holdings

  • Hamilton Lane Advisors LLC

    10.11%

  • SFI Advisors, LLC

    2.04%

  • MASSMUTUAL TRUST CO FSB/ADV

    1.37%

  • Vanguard Group Inc

    1.15%

  • Northern Trust Corp

    0.29%

  • Geode Capital Management, LLC

    0.26%

Company Information

founded in 1989, cryo-cell is the oldest cord blood bank and was the first cord blood bank to separate and store stem cells in 1992. today, the company has over 270,000 clients worldwide. since inception, 100% of our clients’ specimens have been successfully viable upon thaw. our services include umbilical cord blood, cord tissue and menstrual stem cell banking. cryo-cell operates its own state-of-the-art processing, testing and cryopreservation operation. we are in complete control of every step, ensuring the highest quality available today.

Organization
Cryo-cell International Inc
Employees
82
CEO
Mr. David I. Portnoy
Industry
Services to the Health Industry

Discover More

FAQs